Aggregated by Superinsight from public-domain sources, as of 2026-08-20.
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.02
3.02 Chronic respiratory disorders due to any cause except CF (for CF, see 3.04) with A, B, C, or D:
A. FEV1 (see 3.00E) less than or equal to the value in Table I-A or I-B for your age, sex, and height without shoes (see 3.00E3a).
OR
B. FVC (see 3.00E) less than or equal to the value in Table II-A or II-B for your age, sex, and height without shoes (see 3.00E3a).
OR
C. Chronic impairment of gas exchange demonstrated by 1, 2, or 3:
Average of two unadjusted, single-breath DLCO measurements (see 3.00F) less than or equal to the value in Table III for your sex and height without shoes (see 3.00F3a); or
Arterial PaO2 and PaCO2 measured concurrently by an ABG test, while at rest or during steady state exercise, breathing room air (see 3.00G3b), less than or equal to the applicable values in Table IV-A, IV-B, or IV-C; or
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.03
3.03 Asthma (see 3.00I), with both A and B:
A. FEV1 (see 3.00E1) less than or equal to the value in Table VI-A or VI-B for your age, sex, and height without shoes (see 3.00E3a) measured within the same 12-month period as the hospitalizations in 3.03B.
AND
B. Exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization. Consider under a disability for 1 year from the discharge date of the last hospitalization; after that, evaluate the residual impairment(s) under 3.03 or another appropriate listing.
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.04
3.04 Cystic fibrosis (documented as described in 3.00J2) with A, B, C, D, E, F, or G:
A. FEV1 (see 3.00E) less than or equal to the value in Table VII-A or VII-B for your age, sex, and height without shoes (see 3.00E3a).
OR
B. Exacerbations or complications (see 3.00J3) requiring three hospitalizations of any length within a 12-month period and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).
OR
C. Spontaneous pneumothorax, secondary to CF, requiring chest tube placement.
OR
D. Respiratory failure (see 3.00N) requiring invasive mechanical ventilation, noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, or for a continuous period of at least 72 hours if postoperatively.
OR
E. Pulmonary hemorrhage requiring vascular embolization to control bleeding.
OR
F. SpO2 measured by pulse oximetry (see 3.00H3) either at rest, during a 6MWT, or after a 6MWT, less than or equal to the value in Table VIII, twice within a 12-month period and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).
OR
G. Two of the following exacerbations or complications (either two of the same or two different, see 3.00J3 and 3.00J4) within a 12-month period (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review):
Pulmonary exacerbation requiring 10 consecutive days of intravenous antibiotic treatment.
Pulmonary hemorrhage (hemoptysis with more than blood-streaked sputum but not requiring vascular embolization) requiring hospitalization of any length.
Weight loss requiring daily supplemental enteral nutrition via a gastrostomy for at least 90 consecutive days or parenteral nutrition via a central venous catheter for at least 90 consecutive days.
CFRD requiring daily insulin therapy for at least 90 consecutive days.
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.05
3.05 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.06
3.06 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.07
3.07 Bronchiectasis (see 3.00K), documented by imaging (see 3.00D3), with exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization.
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.08
3.08 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.09
3.09 Chronic pulmonary hypertension due to any cause (see 3.00L) documented by mean pulmonary artery pressure equal to or greater than 40 mm Hg as determined by cardiac catheterization while medically stable (see 3.00E2a).
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.10
3.10 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.11
3.11 Lung transplantation (see 3.00M). Consider under a disability for 3 years from the date of the transplant; after that, evaluate the residual impairment(s).
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.12
3.12 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.13
3.13 [Reserved]
20 C.F.R. Pt. 404, Subpt. P, App. 1, § 3.14
3.14 Respiratory failure (see 3.00N) resulting from any underlying chronic respiratory disorder except CF (for CF, see 3.04D), requiring invasive mechanical ventilation, noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, or for a continuous period of at least 72 hours if postoperatively, twice within a 12-month period and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).